{
  "metadata": {
    "version": "1.0",
    "last_updated": "2025-12-10",
    "source": "Amundi ETF documentation and official PEA eligibility lists",
    "warning": "PEA eligibility can change. Always verify current status with broker and AMF before investing.",
    "disclaimer": "This data is for personal information only. Not investment advice."
  },
  "etfs": [
    {
      "ticker": "LQQ",
      "isin": "FR0010342592",
      "name": "Amundi Nasdaq-100 Daily (2x) Leveraged UCITS ETF",
      "name_fr": "Amundi Nasdaq-100 Daily (2x) Leveraged UCITS ETF",
      "provider": "Amundi",
      "underlying_index": "NASDAQ-100",
      "underlying_index_description": "100 largest non-financial companies listed on NASDAQ",
      "leverage_factor": 2.0,
      "leverage_type": "daily",
      "leverage_reset": "daily",
      "replication_method": "synthetic",
      "replication_method_fr": "synthétique (swap)",
      "accumulating": true,
      "dividend_policy": "Accumulating (reinvested)",
      "dividend_policy_fr": "Capitalisation (dividendes réinvestis)",
      "currency": "EUR",
      "ter_percent": 0.60,
      "ter_notes": "Total Expense Ratio includes management fees and operational costs. Higher than non-leveraged ETFs due to leverage costs.",
      "pea_eligible": true,
      "pea_eligibility_basis": "UCITS ETF domiciled in France with sufficient EU equity exposure",
      "domicile": "France",
      "listing_exchange": "Euronext Paris",
      "inception_date": "2008-07-07",
      "aum_approximate_eur": "1B+",
      "average_daily_volume": "High liquidity",
      "primary_exposure": "US Technology sector via leveraged Nasdaq-100",
      "primary_exposure_fr": "Secteur technologique américain via effet de levier Nasdaq-100",
      "geographic_exposure": {
        "US": 100,
        "EU": 0,
        "other": 0
      },
      "sector_concentration": {
        "Technology": 60,
        "Consumer Discretionary": 20,
        "Communication Services": 15,
        "Other": 5
      },
      "top_holdings_note": "Synthetic replication via swap. Physical holdings may differ from index components.",
      "risks": [
        "2x daily leverage amplifies both gains and losses",
        "Volatility decay in sideways or volatile markets",
        "Daily rebalancing creates path dependency",
        "High TER (0.60%) reduces long-term returns",
        "Concentrated exposure to US tech sector",
        "Currency risk (USD/EUR) despite EUR denomination",
        "Counterparty risk from synthetic replication",
        "Not suitable for long-term buy-and-hold without monitoring"
      ],
      "risks_fr": [
        "Effet de levier 2x quotidien amplifie gains et pertes",
        "Érosion par volatilité dans marchés latéraux ou volatils",
        "Rebalançage quotidien crée dépendance au chemin",
        "TER élevé (0,60%) réduit rendements long terme",
        "Exposition concentrée au secteur tech américain",
        "Risque de change (USD/EUR) malgré cotation en EUR",
        "Risque de contrepartie lié à réplication synthétique",
        "Inadapté au buy-and-hold long terme sans surveillance"
      ],
      "suitable_for": [
        "Experienced investors with high risk tolerance",
        "Short to medium-term tactical allocation",
        "Active monitoring and portfolio management",
        "Bullish conviction on US tech sector"
      ],
      "suitable_for_fr": [
        "Investisseurs expérimentés à tolérance au risque élevée",
        "Allocation tactique court à moyen terme",
        "Surveillance active et gestion de portefeuille",
        "Conviction haussière sur secteur tech américain"
      ],
      "not_suitable_for": [
        "Risk-averse investors",
        "Long-term passive investors",
        "Retirement core holdings",
        "Investors who cannot monitor positions regularly"
      ],
      "links": {
        "amundi_product_page": "https://www.amundietf.fr/fr/professional/products/equity/amundi-nasdaq-100-daily-2x-leveraged-ucits-etf-acc/fr0010342592",
        "kiid": "https://www.amundietf.fr/kiid/FR0010342592",
        "factsheet": "https://www.amundietf.fr/factsheet/FR0010342592"
      }
    },
    {
      "ticker": "CL2",
      "isin": "FR0010755611",
      "name": "Amundi MSCI USA Daily (2x) Leveraged UCITS ETF",
      "name_fr": "Amundi MSCI USA Daily (2x) Leveraged UCITS ETF",
      "provider": "Amundi",
      "underlying_index": "MSCI USA",
      "underlying_index_description": "Large and mid-cap stocks across the US equity market",
      "leverage_factor": 2.0,
      "leverage_type": "daily",
      "leverage_reset": "daily",
      "replication_method": "synthetic",
      "replication_method_fr": "synthétique (swap)",
      "accumulating": true,
      "dividend_policy": "Accumulating (reinvested)",
      "dividend_policy_fr": "Capitalisation (dividendes réinvestis)",
      "currency": "EUR",
      "ter_percent": 0.50,
      "ter_notes": "Total Expense Ratio includes management fees and operational costs. Lower than LQQ but still high due to leverage costs.",
      "pea_eligible": true,
      "pea_eligibility_basis": "UCITS ETF domiciled in France with sufficient EU equity exposure",
      "domicile": "France",
      "listing_exchange": "Euronext Paris",
      "inception_date": "2010-03-18",
      "aum_approximate_eur": "500M+",
      "average_daily_volume": "Moderate to high liquidity",
      "primary_exposure": "Broad US equity market via leveraged MSCI USA",
      "primary_exposure_fr": "Marché actions américain large via effet de levier MSCI USA",
      "geographic_exposure": {
        "US": 100,
        "EU": 0,
        "other": 0
      },
      "sector_concentration": {
        "Technology": 30,
        "Financials": 15,
        "Healthcare": 13,
        "Consumer Discretionary": 11,
        "Communication Services": 9,
        "Industrials": 8,
        "Consumer Staples": 6,
        "Other": 8
      },
      "top_holdings_note": "Synthetic replication via swap. Physical holdings may differ from index components.",
      "risks": [
        "2x daily leverage amplifies both gains and losses",
        "Volatility decay in sideways or volatile markets",
        "Daily rebalancing creates path dependency",
        "High TER (0.50%) reduces long-term returns",
        "Broad but concentrated exposure to US market",
        "Currency risk (USD/EUR) despite EUR denomination",
        "Counterparty risk from synthetic replication",
        "Sector concentration risk (tech, financials)"
      ],
      "risks_fr": [
        "Effet de levier 2x quotidien amplifie gains et pertes",
        "Érosion par volatilité dans marchés latéraux ou volatils",
        "Rebalançage quotidien crée dépendance au chemin",
        "TER élevé (0,50%) réduit rendements long terme",
        "Exposition large mais concentrée sur marché américain",
        "Risque de change (USD/EUR) malgré cotation en EUR",
        "Risque de contrepartie lié à réplication synthétique",
        "Risque de concentration sectorielle (tech, finance)"
      ],
      "suitable_for": [
        "Experienced investors with high risk tolerance",
        "Short to medium-term tactical allocation",
        "Active monitoring and portfolio management",
        "Bullish conviction on broad US equity market",
        "Diversification alternative to Nasdaq-focused LQQ"
      ],
      "suitable_for_fr": [
        "Investisseurs expérimentés à tolérance au risque élevée",
        "Allocation tactique court à moyen terme",
        "Surveillance active et gestion de portefeuille",
        "Conviction haussière sur marché actions américain large",
        "Alternative de diversification au LQQ focalisé Nasdaq"
      ],
      "not_suitable_for": [
        "Risk-averse investors",
        "Long-term passive investors",
        "Retirement core holdings",
        "Investors who cannot monitor positions regularly"
      ],
      "links": {
        "amundi_product_page": "https://www.amundietf.fr/fr/professional/products/equity/amundi-msci-usa-daily-2x-leveraged-ucits-etf-acc/fr0010755611",
        "kiid": "https://www.amundietf.fr/kiid/FR0010755611",
        "factsheet": "https://www.amundietf.fr/factsheet/FR0010755611"
      }
    },
    {
      "ticker": "WPEA",
      "isin": "FR0011869353",
      "name": "Amundi MSCI World UCITS ETF EUR (C)",
      "name_fr": "Amundi MSCI World UCITS ETF EUR (C)",
      "provider": "Amundi",
      "underlying_index": "MSCI World",
      "underlying_index_description": "Large and mid-cap stocks across developed markets worldwide",
      "leverage_factor": 1.0,
      "leverage_type": "none",
      "leverage_reset": "N/A",
      "replication_method": "synthetic",
      "replication_method_fr": "synthétique (swap)",
      "accumulating": true,
      "dividend_policy": "Accumulating (reinvested)",
      "dividend_policy_fr": "Capitalisation (dividendes réinvestis)",
      "currency": "EUR",
      "ter_percent": 0.38,
      "ter_notes": "Total Expense Ratio. Competitive for global equity exposure. Note: Some sources indicate TER closer to 0.20% for similar Amundi World ETFs; verify current prospectus.",
      "pea_eligible": true,
      "pea_eligibility_basis": "UCITS ETF domiciled in France structured to meet PEA eligibility requirements (75%+ EU exposure through specific construction)",
      "domicile": "France",
      "listing_exchange": "Euronext Paris",
      "inception_date": "2013-12-20",
      "aum_approximate_eur": "Multi-billion EUR",
      "average_daily_volume": "High liquidity",
      "primary_exposure": "Global developed markets equity",
      "primary_exposure_fr": "Actions mondiales marchés développés",
      "geographic_exposure": {
        "US": 70,
        "EU": 15,
        "Japan": 6,
        "UK": 4,
        "Canada": 3,
        "Other": 2
      },
      "sector_concentration": {
        "Technology": 24,
        "Financials": 15,
        "Healthcare": 12,
        "Consumer Discretionary": 11,
        "Industrials": 10,
        "Communication Services": 8,
        "Consumer Staples": 7,
        "Energy": 4,
        "Materials": 4,
        "Utilities": 3,
        "Real Estate": 2
      },
      "top_holdings_note": "Synthetic replication. Broad diversification across 1,500+ companies in developed markets.",
      "risks": [
        "Market risk from global equity exposure",
        "Currency risk (primarily USD exposure despite EUR denomination)",
        "Counterparty risk from synthetic replication",
        "Concentration in US market (70% of index)",
        "Sector concentration risk (technology 24%)",
        "No leverage, but still subject to market volatility",
        "Liquidity risk in smaller positions"
      ],
      "risks_fr": [
        "Risque de marché lié à exposition actions mondiales",
        "Risque de change (exposition USD majoritaire malgré cotation EUR)",
        "Risque de contrepartie lié à réplication synthétique",
        "Concentration sur marché américain (70% de l'indice)",
        "Risque de concentration sectorielle (technologie 24%)",
        "Pas de levier, mais soumis à volatilité de marché",
        "Risque de liquidité sur positions plus petites"
      ],
      "suitable_for": [
        "Long-term investors seeking global diversification",
        "Core portfolio holding for PEA accounts",
        "Moderate to high risk tolerance investors",
        "Passive buy-and-hold strategy",
        "Retirement savings with long time horizon",
        "Complementary position to balance leveraged ETFs"
      ],
      "suitable_for_fr": [
        "Investisseurs long terme cherchant diversification mondiale",
        "Position cœur de portefeuille pour comptes PEA",
        "Investisseurs tolérance au risque modérée à élevée",
        "Stratégie passive buy-and-hold",
        "Épargne retraite avec horizon long terme",
        "Position complémentaire pour équilibrer ETF à levier"
      ],
      "not_suitable_for": [
        "Very conservative investors",
        "Short-term trading (due to lower volatility)",
        "Investors seeking only European exposure",
        "Investors uncomfortable with synthetic replication"
      ],
      "links": {
        "amundi_product_page": "https://www.amundietf.fr/fr/professional/products/equity/amundi-msci-world-ucits-etf-eur-c/fr0011869353",
        "kiid": "https://www.amundietf.fr/kiid/FR0011869353",
        "factsheet": "https://www.amundietf.fr/factsheet/FR0011869353"
      }
    }
  ],
  "comparison": {
    "leverage_comparison": {
      "LQQ": {
        "leverage": "2x daily",
        "volatility": "Highest - technology sector concentration",
        "ter": "0.60%",
        "suitable_horizon": "Short to medium-term (with active monitoring)",
        "risk_level": "Very High"
      },
      "CL2": {
        "leverage": "2x daily",
        "volatility": "High - broad market but leveraged",
        "ter": "0.50%",
        "suitable_horizon": "Short to medium-term (with active monitoring)",
        "risk_level": "Very High"
      },
      "WPEA": {
        "leverage": "None (1x)",
        "volatility": "Moderate - diversified global exposure",
        "ter": "~0.20-0.38%",
        "suitable_horizon": "Long-term buy-and-hold (5+ years)",
        "risk_level": "Moderate to High"
      }
    },
    "allocation_strategies": {
      "aggressive_growth": {
        "description": "Maximum growth potential with high risk",
        "allocation": {
          "LQQ": 40,
          "CL2": 40,
          "WPEA": 20
        },
        "risk_profile": "Very High",
        "monitoring_frequency": "Weekly",
        "notes": "Requires active management and high risk tolerance. Not suitable for most investors."
      },
      "balanced_growth": {
        "description": "Growth with moderate risk through diversification",
        "allocation": {
          "LQQ": 25,
          "CL2": 25,
          "WPEA": 50
        },
        "risk_profile": "High",
        "monitoring_frequency": "Bi-weekly to monthly",
        "notes": "More sustainable for medium-term horizons. WPEA provides stability."
      },
      "conservative_growth": {
        "description": "Stable growth with limited leverage exposure",
        "allocation": {
          "LQQ": 10,
          "CL2": 10,
          "WPEA": 80
        },
        "risk_profile": "Moderate to High",
        "monitoring_frequency": "Monthly",
        "notes": "Suitable for longer time horizons and lower risk tolerance. Leveraged positions as satellite holdings."
      },
      "core_only": {
        "description": "Pure global diversification without leverage",
        "allocation": {
          "LQQ": 0,
          "CL2": 0,
          "WPEA": 100
        },
        "risk_profile": "Moderate",
        "monitoring_frequency": "Quarterly",
        "notes": "Most suitable for long-term PEA holders (5+ years). Classic buy-and-hold strategy."
      }
    }
  },
  "tax_considerations": {
    "pea_tax_treatment": {
      "holding_period_less_than_5_years": {
        "tax_on_gains": "PFU 30% (12.8% income tax + 17.2% social charges) OR progressive income tax scale + 17.2% social charges",
        "withdrawal_consequence": "Permanent closure of PEA",
        "notes": "Very unfavorable. Avoid withdrawals before 5 years."
      },
      "holding_period_5_years_or_more": {
        "tax_on_gains": "0% income tax + 17.2% social charges on gains only",
        "withdrawal_consequence": "Partial withdrawals allowed without closure. New contributions prohibited after first withdrawal.",
        "notes": "Significant tax advantage. Primary reason to use PEA."
      },
      "contribution_limit": "€150,000 maximum (excluding gains)",
      "pea_pme_additional_limit": "€225,000 additional for PEA-PME",
      "optimal_strategy": "Hold for minimum 5 years to benefit from income tax exemption"
    },
    "accumulating_advantage": {
      "description": "All three ETFs are accumulating (capitalizing), meaning dividends are automatically reinvested",
      "benefit": "No taxable event from dividends while holding. Only taxed on final gains upon withdrawal.",
      "comparison_to_distributing": "Distributing ETFs would trigger annual taxation on dividends, reducing compounding effect."
    }
  },
  "monitoring_requirements": {
    "eligibility_checks": {
      "frequency": "Quarterly",
      "sources": [
        "Broker's PEA-eligible ETF list",
        "Amundi official communications",
        "AMF official register"
      ],
      "action_if_ineligible": "Immediate sale required to maintain PEA status"
    },
    "performance_monitoring": {
      "frequency": "Monthly for WPEA, Weekly for LQQ/CL2",
      "key_metrics": [
        "Total return vs. benchmark",
        "Tracking error",
        "Volatility decay (for leveraged ETFs)",
        "Portfolio allocation drift"
      ]
    },
    "risk_monitoring": {
      "frequency": "Monthly",
      "key_metrics": [
        "Portfolio volatility",
        "Maximum drawdown",
        "Sharpe ratio",
        "Correlation between positions"
      ],
      "action_triggers": [
        "Rebalance if allocation drifts >5% from target",
        "Consider de-risking if drawdown exceeds personal threshold",
        "Review strategy if volatility decay erodes leveraged positions significantly"
      ]
    }
  },
  "important_notes": [
    "This data is current as of 2025-12-10. Always verify current information before investing.",
    "PEA eligibility can change due to regulatory updates or ETF composition changes.",
    "TER (Total Expense Ratio) is deducted automatically from ETF performance.",
    "Leveraged ETFs (LQQ, CL2) are NOT suitable for passive buy-and-hold without active monitoring.",
    "Currency risk exists despite EUR denomination due to underlying US equity exposure.",
    "Synthetic replication involves counterparty risk - review KIID documents for details.",
    "This is personal reference data, not investment advice. Consult a professional advisor for personalized guidance.",
    "Always read the KIID (Key Investor Information Document) before investing.",
    "Past performance does not predict future results.",
    "You can lose all of your invested capital."
  ],
  "important_notes_fr": [
    "Ces données sont à jour au 2025-12-10. Toujours vérifier les informations actuelles avant d'investir.",
    "L'éligibilité au PEA peut changer suite à des mises à jour réglementaires ou des changements de composition des ETF.",
    "Les TER (frais totaux) sont automatiquement déduits de la performance de l'ETF.",
    "Les ETF à levier (LQQ, CL2) ne conviennent PAS à une stratégie buy-and-hold passive sans surveillance active.",
    "Le risque de change existe malgré la cotation en EUR en raison de l'exposition sous-jacente aux actions américaines.",
    "La réplication synthétique implique un risque de contrepartie - consultez les DICI pour les détails.",
    "Ceci est une référence personnelle, pas un conseil en investissement. Consultez un conseiller professionnel pour un accompagnement personnalisé.",
    "Lisez toujours le DICI (Document d'Information Clé pour l'Investisseur) avant d'investir.",
    "Les performances passées ne préjugent pas des résultats futurs.",
    "Vous pouvez perdre la totalité de votre capital investi."
  ],
  "resources": {
    "regulatory": {
      "amf": "https://www.amf-france.org",
      "amf_pea_guide": "https://www.amf-france.org/fr/espace-epargnants/comprendre-les-produits-financiers/comptes-titres-pea",
      "euronext_etf_list": "https://www.euronext.com/en/products/etfs"
    },
    "provider": {
      "amundi_etf_homepage": "https://www.amundietf.fr",
      "amundi_pea_guide": "https://www.amundietf.fr/fr/solutions/pea"
    },
    "tax": {
      "impots_gouv": "https://www.impots.gouv.fr",
      "bofip_pea": "https://bofip.impots.gouv.fr (search for 'PEA')"
    }
  }
}
